Last $15.00 USD
Change Today +0.30 / 2.04%
Volume 84.1K
FLML On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen H. Willard Esq.

Non-Executive Chairman and Member of Compensation Committee, Flamel Technologies SA
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 2 different industries.

See Board Relationships
53--

Background*

Mr. Stephen H. Willard, also known as Steve, Esq. served as the Chief Executive Officer of Flamel Technologies SA from June 22, 2005 to March 12, 2012. Mr. Willard served as an Executive Vice President, Chief Financial Officer and General Counsel of Flamel Technologies SA since August 2000. Prior to joining Flamel Technologies S.A., in August 2000, he served as a Vice President of Biovail Corporation International. He served as Vice President of CS First Boston in New ...

Read Full Background

Corporate Headquarters*

Parc Club du Moulin à Vent
Vénissieux, Rhône-Alpes 69693

France

Phone: 33 472 78 34 34
Fax: 33 472 78 34 35

Board Members Memberships*

2000-Present
Non-Executive Chairman and Member of Compensation Committee
2005-2014
Former Director, Member of Compensation Committee and Member of Risk Oversight Committee

Education*

BA 1982
Williams College
JD 1985
Yale Law School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FLML:US $15.00 USD +0.30

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Ronald W. Barrett Ph.D.Co-Founder, Chief Executive Officer and Director
Xenoport, Inc.
$500.0K
Judith Greciet Ph.D., PharmacyChief Executive Officer, Director and Member of Corporate Development Committee
Onxeo SA
€276.9K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$739.3K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FLAMEL TECHNOLOGIES-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.